Role of SIRT3 in the regulation of redox balance during oral carcinogenesis

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Chen, I Chieh ^a   Chiang, Wei Fan ^b,c   Liu, Shyun Yeu ^b   Chen, Pei Fen ^a   Chiang, Hung Che ^a,d,e  

^a National Health   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Human oral keratinocyte; Oral squamous cell carcinoma; Reactive oxygen species; Sirtuin 3

Indexed keywords

CELL DNA; REACTIVE OXYGEN METABOLITE; SIRTUIN 3;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; GENE SEQUENCE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MISSENSE MUTATION; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION;

BASE SEQUENCE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC VARIATION; HUMANS; MOUTH NEOPLASMS; MUTATION; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIRTUIN 3;

EID: 84879119336     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-68     Document Type: Article

References (52)

1. Bsoul SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract 2005, 6:1-16.
2. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, Chang KW. Genome-wide profiling of oral squamous cell carcinoma. J Pathol 2004, 204:326-332. 10.1002/path.1640, 15372456.
3. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001, 37:477-492. 10.1016/S1368-8375(01)00003-3, 11435174.
4. Sharma DC. Betel quid and areca nut are carcinogenic without tobacco. Lancet Oncol 2003, 4:587-587.
5. Liu TY, Chen CL, Chi CW. Oxidative damage to DNA induced by areca nut extract. Mutat Res-Genet Tox 1996, 367:25-31.
6. Chang MC, Ho YS, Lee PH, Chan CP, Lee JJ, Hahn LJ, Wang YJ, Jeng JH. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis 2001, 22:1527-1535. 10.1093/carcin/22.9.1527, 11532876.
7. Tang DW, Lin SC, Chang KW, Chi CW, Chang CS, Liu TY. Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma-evidence for COX-2 induction by areca quid ingredients in oral keratinocytes. J Oral Pathol Med 2003, 32:522-529. 10.1034/j.1600-0714.2003.00182.x, 12969226.
8. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495. 10.1016/j.cell.2005.02.001, 15734681.
9. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40. 10.1016/j.cbi.2005.12.009, 16430879.
10. Taylor DM, Maxwell MM, Luthi-Carter R, Kazantsev AG. Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci 2008, 65:4000-4018. 10.1007/s00018-008-8357-y, 18820996.
11. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800. 10.1038/35001622, 10693811.
12. Lin SJ, Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 2003, 15:241-246. 10.1016/S0955-0674(03)00006-1, 12648681.
13. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007, 26:5489-5504. 10.1038/sj.onc.1210616, 17694089.
14. Haigis MC, Guarente LP. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006, 20:2913-2921. 10.1101/gad.1467506, 17079682.
15. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007, 404:1-13. 10.1042/BJ20070140, 2753453, 17447894.
16. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005, 16:4623-4635. 10.1091/mbc.E05-01-0033, 1237069, 16079181.
17. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA 2002, 99:13653-13658. 10.1073/pnas.222538099, 129731, 12374852.
18. Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 2002, 158:647-657. 10.1083/jcb.200205057, 2174009, 12186850.
19. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125. 10.1038/nature08778, 2841477, 20203611.
20. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010, 12:662-667. 10.1016/j.cmet.2010.11.015, 21109198.
21. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812. 10.1016/j.cell.2010.10.002, 3018849, 21094524.
22. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007, 27:8807-8814. 10.1128/MCB.01636-07, 2169418, 17923681.
23. Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, Lombard DB, Li Y, Bunkenborg J, Alt FW, Denu JM, et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 2010, 12:654-661. 10.1016/j.cmet.2010.11.003, 3310379, 21109197.
24. Hallows WC, Yu W, Smith BC, Devries MK, Ellinger JJ, Someya S, Shortreed MR, Prolla T, Markley JL, Smith LM, et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell 2011, 41:139-149. 10.1016/j.molcel.2011.01.002, 3101115, 21255725.
25. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010, 40:893-904. 10.1016/j.molcel.2010.12.013, 3266626, 21172655.
26. Guan KL, Xiong Y. Regulation of intermediary metabolism by protein acetylation. Trends Biochem Sci 2011, 36:108-116. 10.1016/j.tibs.2010.09.003, 3038179, 20934340.
27. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, et al. SIRT3 Is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52. 10.1016/j.ccr.2009.11.023, 20129246.
28. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011, 19:416-428. 10.1016/j.ccr.2011.02.014, 3065720, 21397863.
29. Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011, 30:2986-2996. 10.1038/onc.2011.37, 3134877, 21358671.
30. Jing E, Emanuelli B, Hirschey MD, Boucher J, Lee KY, Lombard D, Verdin EM, Kahn CR. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci USA 2011, 108:14608-14613. 10.1073/pnas.1111308108, 3167496, 21873205.
31. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009, 119:2758-2771. 2735933, 19652361.
32. Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 2011, 44:177-190. 10.1016/j.molcel.2011.07.019, 3563434, 21856199.
33. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F, Chang Y. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010, 5:e11707. 10.1371/journal.pone.0011707, 2908542, 20661474.
34. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000, 273:793-798. 10.1006/bbrc.2000.3000, 10873683.
35. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008, 87:14-32. 10.1177/154405910808700104, 18096889.
36. Hillbertz NS, Hirsch JM, Jalouli J, Jalouli MM, Sand L. Viral and molecular aspects of oral cancer. Anticancer Res 2012, 32:4201-4212.
37. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009, 119:524-530. 10.1172/JCI36703, 2648681, 19197138.
38. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591. 10.1038/nature08197, 19641587.
39. Giralt A, Hondares E, Villena JA, Ribas F, Diaz-Delfin J, Giralt M, Iglesias R, Villarroya F. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J Biol Chem 2011, 286:16958-16966. 10.1074/jbc.M110.202390, 3089539, 21454513.
40. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005, 280:13560-13567. 10.1074/jbc.M414670200, 15653680.
41. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008, 382:790-801. 10.1016/j.jmb.2008.07.048, 18680753.
42. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010, 3:ra3. 10.1126/scisignal.2000475, 20068231.
43. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, Passarino G, Feraco E, Mari V, Barbi C, et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 2003, 38:1065-1070. 10.1016/S0531-5565(03)00209-2, 14580859.
44. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, et al. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005, 85:258-263. 10.1016/j.ygeno.2004.11.003, 15676284.
45. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, Thorleifsson G, Zillikens MC, Speliotes EK, Magi R, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010, 42:949-960. 10.1038/ng.685, 3000924,3000924, 20935629.
46. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (vol 42, pg 105, 2010). Nat Genet 2010, 42:464-464.
47. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713. 10.1038/nature09270, 3039276, 20686565.
48. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, Li XY, Li H, Kuperwasser N, Ruda VM, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-U712. 10.1038/nature09266, 3062476, 20686566.
49. Marfe G, Tafani M, Indelicato M, Sinibaldi-Salimei P, Reali V, Pucci B, Fini M, Russo MA. Kaempferol induces apoptosis in Two different cell lines Via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem 2009, 106:643-650. 10.1002/jcb.22044, 19160423.
50. Allison SJ, Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007, 6:2669-2677. 10.4161/cc.6.21.4866, 17957139.
51. Schumacker PT. A tumor suppressor SIRTainty. Cancer Cell 2010, 17:5-6. 10.1016/j.ccr.2009.12.032, 20129243.
52. Slane BG, Aykin-Burns N, Smith BJ, Kalen AL, Goswami PC, Domann FE, Spitz DR. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res 2006, 66:7615-7620. 10.1158/0008-5472.CAN-06-0833, 16885361.